Slingshot Therapeutics

Slingshot Therapeutics is a drug discovery accelerator that identifies early-stage scientific programmes from academic institutions and advances them towards clinical development.

The company provides centralised expertise, operational infrastructure, and funding to progress small molecule candidates through preclinical development.

Backed by life science investor Syncona, Slingshot operates across a broad range of therapeutic areas with an initial focus on inflammatory disease.